CDT
CDT Equity Inc.NASDAQHealthcare$3.95+0.00%ClosedMarket Cap: $698,514
As of 2026-04-06
Valuation
View DetailsP/E (TTM)
0.00
PEG
0.00
P/B
0.00
P/S
0.00
EV/EBITDA
12.50
DCF Value
$1,999,073.60
FCF Yield
31308.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
36.5%
Operating Margin
43.8%
Net Margin
33.0%
ROE
74.5%
ROA
6.7%
ROIC
11.1%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $720.1M | $255.4M | $425.00 |
| FY 2025 | $2.72B | $237.5M | $1,477.50 |
| Q3 2025 | $0.00 | $-7.1M | $1,000.00 |
| Q2 2025 | $0.00 | $-6.0M | $382.50 |
Trading Activity
Insider Trades
View AllTaylor Mark Andrew10 percent owner
SellMon Mar 30
Taylor Mark Andrew10 percent owner
SellMon Mar 30
Taylor Mark Andrew10 percent owner
SellMon Mar 30
Taylor Mark Andrew10 percent owner
SellMon Mar 30
Taylor Mark Andrew10 percent owner
SellMon Mar 30
Company Info
Sector
Healthcare
Industry
—
Country
US
Exchange
NASDAQ
Beta
2.08
CDT Equity, Inc. engages in facilitating the development and commercialization of clinical assets. The company was founded by David Joszef Tapolczay and Freda C. Lewis-Hall in October 2021 is headquartered in Naples, FL.